Clinical Performance of Advanced Self- Adhesivee Resin Composite Hybrid Restorations.
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04790383 |
|
Recruitment Status :
Recruiting
First Posted : March 10, 2021
Last Update Posted : March 10, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Caries Class II Caries,Dental | Other: Advanced Self-Adhesive resin composite hybrid restorations (Surefil one (Dentsply Sirona)). Other: Conventional resin composite restoration. (Sphere Tec, (Dentsply Sirona | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 63 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Clinical Performance of Advanced Self-Adhesive Resin Composite Hybrid Restorations Versus Conventional Resin Composite Restorations in Posterior Teeth (1y Randomized Clinical Trial). |
| Actual Study Start Date : | February 1, 2021 |
| Estimated Primary Completion Date : | February 2022 |
| Estimated Study Completion Date : | March 2022 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Advanced Self-Adhesive resin composite hybrid restorations
(Surefil one (Dentsply Sirona)).
|
Other: Advanced Self-Adhesive resin composite hybrid restorations (Surefil one (Dentsply Sirona)).
Hybrid resin composite that doesn't need bonding system and releases calcium and flouride. |
|
Active Comparator: Conventional resin composite restoration.
Sphere Tec, (Dentsply Sirona)
|
Other: Conventional resin composite restoration. (Sphere Tec, (Dentsply Sirona
Conventional Nanohybrid resin composite |
- Clinical performance [ Time Frame: Change from baseline at 6, 12 months ]
Post operative Hypersensitivity, Secondary caries, Gross fracture, Cavo-surface marginal discoloration, Proximal contact.
All these outcomes are measured by a score Alpha is excellent, Bravo is acceptable, Charlie is not accepted
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 17 Years to 55 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Patients with carious proximal cavities in molars
- Good oral hygiene.
- Presence of favorable occlusion and teeth are in normal contact with the adjacent teeth.
Exclusion Criteria:
- Teeth with signs and symptoms of irreversible pulpitis or pulp necrosis.
- Severe periodontal problems.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04790383
| Contact: Rawda Hesham Hesham A.ElAziz | +201001097200 | rawda.hesham@dentistry.cu.edu.eg | |
| Contact: Dina Ezz Eldin Mohamed | +20 100 800 7157 | Dina.ezz@dentistry.cu.edu.eg |
| Egypt | |
| Cairo University | Recruiting |
| Cairo, Egypt | |
| Contact: Cairo University | |
| Responsible Party: | Rawda Hesham Abd ElAziz, lecturer at Conservative Dentistry department, Cairo University |
| ClinicalTrials.gov Identifier: | NCT04790383 |
| Other Study ID Numbers: |
CU-2-2021 |
| First Posted: | March 10, 2021 Key Record Dates |
| Last Update Posted: | March 10, 2021 |
| Last Verified: | March 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
self-Adhesive resin composite hybrid restorations Posterior resin composite Surefil One |
|
Dental Caries Tooth Demineralization Tooth Diseases Stomatognathic Diseases Polymethyl Methacrylate |
Vasodilator Agents Antimutagenic Agents Protective Agents Physiological Effects of Drugs |

